$NURO
NeuroMetrix, Inc.

2016 Q1 Form 10-Q Financial Statement

#000114420416095581 Filed on April 21, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $2.275M $1.283M
YoY Change 77.34% -3.65%
Cost Of Revenue $1.483M $637.3K
YoY Change 132.64% 3.61%
Gross Profit $792.7K $645.7K
YoY Change 22.77% -9.88%
Gross Profit Margin 34.84% 50.33%
Selling, General & Admin $3.832M $3.002M
YoY Change 27.67% 88.44%
% of Gross Profit 483.42% 464.89%
Research & Development $1.157M $902.5K
YoY Change 28.17% 4.49%
% of Gross Profit 145.92% 139.78%
Depreciation & Amortization $61.64K $29.14K
YoY Change 111.49% -2.85%
% of Gross Profit 7.78% 4.51%
Operating Expenses $4.989M $3.904M
YoY Change 27.78% 58.93%
Operating Profit -$4.196M -$3.259M
YoY Change 28.77% 87.25%
Interest Expense $100.0K $1.190M
YoY Change -91.6% 128.85%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.100M -$2.070M
YoY Change 98.07% 69.67%
Income Tax
% Of Pretax Income
Net Earnings -$4.095M -$2.071M
YoY Change 97.72% 69.14%
Net Earnings / Revenue -179.99% -161.44%
Basic Earnings Per Share
Diluted Earnings Per Share -$82.00M -$69.00M
COMMON SHARES
Basic Shares Outstanding 4.050M shares 8.153M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.740M $6.400M
YoY Change 36.56% -15.57%
Cash & Equivalents $8.740M $6.403M
Short-Term Investments
Other Short-Term Assets $720.0K $260.0K
YoY Change 176.92% -45.83%
Inventory $1.510M $635.2K
Prepaid Expenses
Receivables $490.0K $921.6K
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.46M $8.223M
YoY Change 39.37% -11.17%
LONG-TERM ASSETS
Property, Plant & Equipment $650.0K $539.7K
YoY Change 20.43% 171.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $190.0K $370.0K
YoY Change -48.65%
Total Long-Term Assets $850.0K $908.1K
YoY Change -6.4% 355.56%
TOTAL ASSETS
Total Short-Term Assets $11.46M $8.223M
Total Long-Term Assets $850.0K $908.1K
Total Assets $12.31M $9.131M
YoY Change 34.82% -3.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.380M $916.5K
YoY Change 50.57% 58.57%
Accrued Expenses $1.880M $1.286M
YoY Change 46.17% 62.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.270M $3.319M
YoY Change -1.47% 68.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $190.0K $4.130M
YoY Change -95.4% 186.81%
Total Long-Term Liabilities $190.0K $4.130M
YoY Change -95.4% 186.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.270M $3.319M
Total Long-Term Liabilities $190.0K $4.130M
Total Liabilities $3.460M $7.449M
YoY Change -53.55% 118.53%
SHAREHOLDERS EQUITY
Retained Earnings -$156.4M
YoY Change 5.83%
Common Stock $439.00 $852.00
YoY Change -48.47% 43.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.850M $1.682M
YoY Change
Total Liabilities & Shareholders Equity $12.31M $9.131M
YoY Change 34.82% -3.43%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$4.095M -$2.071M
YoY Change 97.72% 69.14%
Depreciation, Depletion And Amortization $61.64K $29.14K
YoY Change 111.49% -2.85%
Cash From Operating Activities -$3.620M -$2.640M
YoY Change 37.12% 64.17%
INVESTING ACTIVITIES
Capital Expenditures $28.64K $175.2K
YoY Change -83.65% 4157.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$30.00K -$180.0K
YoY Change -83.33% 4274.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -80.00K
YoY Change
NET CHANGE
Cash From Operating Activities -3.620M -2.640M
Cash From Investing Activities -30.00K -180.0K
Cash From Financing Activities -80.00K
Net Change In Cash -3.730M -2.820M
YoY Change 32.27% 74.91%
FREE CASH FLOW
Cash From Operating Activities -$3.620M -$2.640M
Capital Expenditures $28.64K $175.2K
Free Cash Flow -$3.649M -$2.815M
YoY Change 29.61% 74.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1424341 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
3904318 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
4989010 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4196276 USD
CY2015Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1089 USD
CY2016Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-94316 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3258619 USD
CY2016Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
6705 USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Revenues
Revenues
1282960 USD
CY2016Q1 us-gaap Revenues
Revenues
2275247 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
1482513 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1455686 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1546090 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28643 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
175181 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
197589 USD
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2068521 shares
CY2015Q1 us-gaap Depreciation
Depreciation
29144 USD
CY2016Q1 us-gaap Depreciation
Depreciation
61638 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
83999 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
66012 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
341355 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-251455 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-44577 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
424238 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-344874 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-142887 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
311487 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
379509 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
317732 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2643681 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3617925 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-175181 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-28643 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2818862 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3723221 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9221985 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6403123 USD
CY2015Q1 nuro Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
-281757 USD
CY2016Q1 nuro Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
-318761 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-76653 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2016Q1 nuro Technology Fees
TechnologyFees
450000 USD
CY2015Q4 nuro Technology Fees
TechnologyFees
450000 USD
CY2016Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
222333 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
336229 USD
CY2016Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
40312 USD
CY2015Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
56284 USD
CY2016Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
111320 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
105422 USD
CY2016Q1 nuro Accrued Personnel Related Obligations
AccruedPersonnelRelatedObligations
75881 USD
CY2015Q4 nuro Accrued Personnel Related Obligations
AccruedPersonnelRelatedObligations
15548 USD
CY2016Q1 nuro Accrued Consulting Fees
AccruedConsultingFees
185000 USD
CY2015Q4 nuro Accrued Consulting Fees
AccruedConsultingFees
92000 USD
CY2016Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
275961 USD
CY2016Q1 nuro Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
185987 USD
CY2016Q1 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
185987 USD
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1865498 USD
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
1865498 USD
CY2015Q4 nuro Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
280303 USD
CY2015Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
280303 USD
CY2016Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2500000 USD
CY2016Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2017-01-15
CY2016Q1 nuro Restricted Cash Collateral Letters Of Credit
RestrictedCashCollateralLettersOfCredit
226731 USD
CY2016Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2300000 USD
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
87714 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90111 USD
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4389899 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4047332 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4047332 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4389899 shares
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-223349 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-56466 USD
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2015Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
82161 USD
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21617179 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2035669 shares
CY2015Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
45000 USD
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 nuro Closing Price Of Shares
ClosingPriceOfShares
1.79
CY2015Q1 nuro Closing Price Of Shares
ClosingPriceOfShares
6.72
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
228753 USD
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2016Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
667457 USD
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
432437 USD
CY2016Q1 nuro Finished Goods On Consignment
FinishedGoodsOnConsignment
23814 USD
CY2015Q4 nuro Finished Goods On Consignment
FinishedGoodsOnConsignment
39784 USD
CY2016Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
822051 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
616863 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2016Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
76653 USD
CY2015Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 USD
CY2016Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
392018 USD
CY2015Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
378440 USD
CY2016Q1 us-gaap Deferred Revenue
DeferredRevenue
553854 USD
CY2015Q4 us-gaap Deferred Revenue
DeferredRevenue
489467 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
439 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
405 USD
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares

Files In Submission

Name View Source Status
0001144204-16-095581-index-headers.html Edgar Link pending
0001144204-16-095581-index.html Edgar Link pending
0001144204-16-095581.txt Edgar Link pending
0001144204-16-095581-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nuro-20160331.xml Edgar Link completed
nuro-20160331.xsd Edgar Link pending
nuro-20160331_cal.xml Edgar Link unprocessable
nuro-20160331_def.xml Edgar Link unprocessable
nuro-20160331_lab.xml Edgar Link unprocessable
nuro-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v436863_10q.htm Edgar Link pending
v436863_ex31-1.htm Edgar Link pending
v436863_ex31-2.htm Edgar Link pending
v436863_ex32.htm Edgar Link pending